23andMe: A Genetic Giant’s Fall Calls for Reform
In the swiftly changing realm of direct-to-consumer genetic testing, few enterprises have left a mark as indelible as 23andMe. Yet, amid its current financial and operational challenges, the debate over the necessity for enhanced regulatory […]
